Cargando…

Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082

Detalles Bibliográficos
Autores principales: Makdissi, Antoine, Chaudhuri, Ajay, Kuhadiya, Nitesh, Batra, Manav, Dandona, Paresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661805/
https://www.ncbi.nlm.nih.gov/pubmed/23704688
http://dx.doi.org/10.2337/dc12-2220
_version_ 1782270744759107584
author Makdissi, Antoine
Chaudhuri, Ajay
Kuhadiya, Nitesh
Batra, Manav
Dandona, Paresh
author_facet Makdissi, Antoine
Chaudhuri, Ajay
Kuhadiya, Nitesh
Batra, Manav
Dandona, Paresh
author_sort Makdissi, Antoine
collection PubMed
description
format Online
Article
Text
id pubmed-3661805
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36618052014-06-01 Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 Makdissi, Antoine Chaudhuri, Ajay Kuhadiya, Nitesh Batra, Manav Dandona, Paresh Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-06 2013-05-15 /pmc/articles/PMC3661805/ /pubmed/23704688 http://dx.doi.org/10.2337/dc12-2220 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Comments and Responses
Makdissi, Antoine
Chaudhuri, Ajay
Kuhadiya, Nitesh
Batra, Manav
Dandona, Paresh
Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_full Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_fullStr Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_full_unstemmed Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_short Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
title_sort comment on: rizzo et al. reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-iv inhibition. diabetes care 2012;35:2076–2082
topic Online Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661805/
https://www.ncbi.nlm.nih.gov/pubmed/23704688
http://dx.doi.org/10.2337/dc12-2220
work_keys_str_mv AT makdissiantoine commentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT chaudhuriajay commentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT kuhadiyanitesh commentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT batramanav commentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082
AT dandonaparesh commentonrizzoetalreductionofoxidativestressandinflammationbybluntingdailyacuteglucosefluctuationsinpatientswithtype2diabetesroleofdipeptidylpeptidaseivinhibitiondiabetescare20123520762082